psilocybin (COMP360) / Compass Pathways  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
psilocybin (COMP360) / Compass Pathways
NCT04519957 / 2020-001348-25: Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)

Completed
N/A
66
Europe, US, RoW
COMPASS Pathways
Treatment Resistant Depression
08/22
08/22
PSILAUT, NCT05651126: Psilocybin in Adults With and Without Autism Spectrum Disorder

Recruiting
N/A
70
Europe
Psilocybin 5 mg, COMP360, Psilocybin 2 mg, Placebo
King's College London, University of Cambridge
Autism Spectrum Disorder
09/25
09/25

Download Options